Median Diagnostics Inc. (XKON:233250)

Market Cap	22.65B
Revenue (ttm)	7.86B
Net Income (ttm)	-567.58M
Shares Out	1.75M
EPS (ttm)	-496.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26
Average Volume	11
Open	12,960
Previous Close	12,500
Day's Range	12,000 - 12,960
52-Week Range	11,000 - 18,500
Beta	0.31
RSI	51.47
Earnings Date	n/a

About Median Diagnostics

Median Diagnostics Inc. develops, produces, and sells diagnostic methods and kits for early diagnosis and constant monitoring of infectious diseases outbreak in animals and human. Its products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and ant...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1999
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 233250